CLINICAL_TRIALS
trial_result
· 2016-07-27
Clinical Trial Update: Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma [NA]
Summary
The clinical trial evaluating neo-adjuvant temsirolimus in patients with advanced renal cell carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Renal Cell Carcinoma | NA | Status: COMPLETED